Acacia Pharma Ltd. - Product Pipeline Review - 2012

Global Markets Direct, July 2012, Pages: 33

Acacia Pharma Ltd. – Product Pipeline Review – 2012

Summary

Global Market Direct’s pharmaceuticals report, “Acacia Pharma Ltd. - Product Pipeline Review - 2012” provides data on the Acacia Pharma Ltd.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Acacia Pharma Ltd.’s corporate website, SEC filings, investor presentations and featured press releases, both from Acacia Pharma Ltd. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Acacia Pharma Ltd. - Brief Acacia Pharma Ltd. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Acacia Pharma Ltd. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
- Product profiles for late stage and clinical stage products of Acacia Pharma Ltd. with complete description of the product’s developmental history, mechanism of action, therapeutic class, target and major milestones.
- Recent updates of the Acacia Pharma Ltd.’s pipeline in the last quarter.
- Key discontinued and dormant projects.
- Latest news and deals relating to the products.

Reasons to buy

- Evaluate Acacia Pharma Ltd.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Acacia Pharma Ltd. in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Acacia Pharma Ltd.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
- Exploit collaboration and partnership opportunities with Acacia Pharma Ltd..
- Avoid Intellectual Property Rights related issues.
- Explore the dormant and discontinued projects of Acacia Pharma Ltd. and identify potential opportunities in those areas.

Keywords

Current R&D Portfolio of Acacia Pharma Ltd.; Acacia Pharma Ltd. - Key Therapeutics; Acacia Pharma Ltd. - Pipeline Overview and Promising Molecules; Acacia Pharma Ltd. - News; Acacia Pharma Ltd. - Latest Updates; Acacia Pharma Ltd. - Pipeline; Acacia Pharma Ltd. - Discontinued/Dormant Projects

2
List of Tables 4
List of Figures 4
Acacia Pharma Ltd. Snapshot 5
Acacia Pharma Ltd. Overview 5
Key Information 5
Key Facts 5
Acacia Pharma Ltd. – Research and Development Overview 6
Key Therapeutic Areas 6
Acacia Pharma Ltd. – Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products – Monotherapy 9
Acacia Pharma Ltd. – Pipeline Products Glance 10
Acacia Pharma Ltd. Clinical Stage Pipeline Products 10
Phase II Products/Combination Treatment Modalities 10
Acacia Pharma Ltd. – Drug Profiles 11
APD209 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
APD403 12
Product Description 12
Mechanism of Action 12
R&D Progress 12
APD421 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
APD515 14
Product Description 14
Mechanism of Action 14
R&D Progress 14
Acacia Pharma Ltd. – Pipeline Analysis 15
Acacia Pharma Ltd. – Pipeline Products by Therapeutic Class 15
Acacia Pharma Ltd. – Pipeline Products By Target 16
Acacia Pharma Ltd. – Pipeline Products by Route of Administration 17
Acacia Pharma Ltd. – Pipeline Products By Mechanism of Action 18
Acacia Pharma Ltd. – Recent Pipeline Updates 19
Acacia Pharma Ltd. - Dormant Projects 21
Acacia Pharma Ltd. - Discontinued Pipeline Products 22
Discontinued Pipeline Product Profiles 22
APD405 22
Acacia Pharma Ltd. – Locations And Subsidiaries 23
Head Office 23
Acacia Pharma Ltd., Recent Developments 24
Acacia Pharma Ltd.- Press Release 24
May 28, 2012: Acacia Pharma Announces Positive Results For APD421 In Post-Operative Nausea & Vomiting 24
Jan 04, 2012: Acacia Pharma Initiates Phase II Study With APD421 In Post-Operative Nausea & Vomiting 24
Dec 14, 2009: Acacia Pharma Completes Phase II Study With APD405 In Post-Operative Nausea & Vomiting (PONV) 25
Jun 08, 2009: Acacia Pharma Initiates Phase II Study With APD405 In Post-Operative Nausea & Vomiting (PONV) 25
Mar 31, 2009: Acacia Pharma Initiates Phase IIa Study With APD209 In Cancer Cachexia Patients 26
Jan 06, 2009: Acacia Pharma Completes Clinical Trial With APD 405 For Nausea & Vomiting 27
Financial Deals Landscape 28
Acacia Pharma Ltd., Deals Summary 28
Acacia Pharma Ltd., Pharmaceuticals & Healthcare, Deal Details 29
Venture Financing 29
Acacia Pharma Secures $10 Million In Series A Financing Round 29
Acacia Pharma Secures Investment From Gilde Healthcare Partners 31
Appendix 32
Methodology 32
Coverage 32
Secondary Research 32
Primary Research 32
Expert Panel Validation 32
Contact Us 33
Disclaimer 33

List of Tables
Acacia Pharma Ltd., Key Information 5
Acacia Pharma Ltd., Key Facts 5
Acacia Pharma Ltd. – Pipeline by Indication, 2012 7
Acacia Pharma Ltd. – Pipeline by Stage of Development, 2012 8
Acacia Pharma Ltd. – Monotherapy Products in Pipeline, 2012 9
Acacia Pharma Ltd. – Phase II, 2012 10
Acacia Pharma Ltd. – Pipeline By Therapeutic Class, 2012 15
Acacia Pharma Ltd. - Pipeline By Target, 2012 16
Acacia Pharma Ltd. – Pipeline By Route of Administration, 2012 17
Acacia Pharma Ltd. – Pipeline Products By Mechanism of Action, 2012 18
Acacia Pharma Ltd. – Recent Pipeline Updates, 2012 19
Acacia Pharma Ltd. - Dormant Developmental Projects,2012 21
Acacia Pharma Ltd. - Discontinued Pipeline Products, 2012 22
Acacia Pharma Ltd., Deals Summary 28
Acacia Pharma Secures $10 Million In Series A Financing Round 29
Acacia Pharma Secures Investment From Gilde Healthcare Partners 31

List of Figures
Acacia Pharma Ltd. – Pipeline by Indication, 2012 7
Acacia Pharma Ltd. – Pipeline by Stage of Development, 2012 8
Acacia Pharma Ltd. – Monotherapy Products in Pipeline, 2012 9
Acacia Pharma Ltd. – Pipeline By Therapeutic Class, 2012 15
Acacia Pharma Ltd. – Pipeline By Route of Administration, 2012 17
Acacia Pharma Ltd. - Pipeline Products By Mechanism of Action, 2012 18

Customers who bought this item also bought

• Top Five Global Software Companies: Performance, Strategies and Competitive Analysis
• eBay - Strong Execution
• Apple, Inc. - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Hewlett-Packard Company - Strategies, Financial Outlook and Competitive Benchmark Analysis
• Amazon - Point of Realization in 2013?
• Scientific Games Corporation - Company Analysis
• SunGard - Profile - US
• Ixia - Company Analysis
• Insight into Samsung Electronics' Notebook PC Business Model
• Accenture - Profile - US